Industry: Healthcare
Published Date: July-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 169
Report ID: PMRREP12646
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Precision Medicine Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.2. Market Overview
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Forecast Factors – Relevance and Impact
4.6. Technology Advancement
4.7. Application Expansion
4.8. Research Funding
5. Global Precision Medicine Market Analysis and Forecasts, By Technology
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Technology Type
5.3. Y-o-Y Growth Projections By Technology Type
5.4. Market value Forecast By Technology, 2024–2031
5.4.1. NGS
5.4.2. Drug Discovery Technologies
5.4.3. Bioinformatics
5.5. Prominent Trends
5.6. Market Attractiveness By Technology
6. Global Precision Medicine Market Analysis and Forecasts, By Application
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Application
6.3. Y-o-Y Growth Projections By Application
6.4. Market value Forecast By Application, 2024–2031
6.4.1. Oncology
6.4.2. Immunology
6.4.3. Neurology
6.4.4. Cardiology
6.4.5. Infectious Diseases
6.4.6. Others
6.5. Prominent Trends
6.6. Market Attractiveness By Application
7. Global Precision Medicine Market Analysis and Forecasts, By Region
7.1. Basis Point Share (BPS) Analysis By Region
7.2. Y-o-Y Growth Projections By Region
7.3. Market value Forecast By Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa
7.4. Market Attractiveness By Region
8. North America Precision Medicine Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Country
8.1.2. Y-o-Y Growth Projections By Country
8.1.3. Key Regulations
8.2. Market value Forecast By Technology, 2024–2031
8.2.1. NGS
8.2.2. Drug Discovery Technologies
8.2.3. Bioinformatics
8.3. Market value Forecast By Application, 2024–2031
8.3.1. Oncology
8.3.2. Immunology
8.3.3. Neurology
8.3.4. Cardiology
8.3.5. Infectious Diseases
8.3.6. Others
8.4. Market value Forecast By Country, 2024–2031
8.4.1. U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Technology
8.5.2. By Application
8.5.3. By Country
8.6. Prominent Trends
8.7. Drivers and Restraints: Impact Analysis
9. Latin America Precision Medicine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.1.3. Key Regulations
9.2. Market value Forecast By Technology, 2024–2031
9.2.1. NGS
9.2.2. Drug Discovery Technologies
9.2.3. Bioinformatics
9.3. Market value Forecast By Application, 2024–2031
9.3.1. Oncology
9.3.2. Immunology
9.3.3. Neurology
9.3.4. Cardiology
9.3.5. Infectious Diseases
9.3.6. Others
9.4. Market value Forecast By Country, 2024–2031
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Market Attractiveness Analysis
9.5.1. By Technology
9.5.2. By Application
9.5.3. By Country
9.6. Prominent Trends
9.7. Drivers and Restraints: Impact Analysis
10. Europe Precision Medicine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2. Market value Forecast By Technology, 2024–2031
10.2.1. NGS
10.2.2. Drug Discovery Technologies
10.2.3. Bioinformatics
10.3. Market value Forecast By Application, 2024–2031
10.3.1. Oncology
10.3.2. Immunology
10.3.3. Neurology
10.3.4. Cardiology
10.3.5. Infectious Diseases
10.3.6. Others
10.4. Market value Forecast By Country, 2024–2031
10.4.1. U.K.
10.4.2. France
10.4.3. Germany
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Technology
10.5.2. By Application
10.5.3. By Country
10.6. Prominent Trends
10.7. Drivers and Restraints: Impact Analysis
11. Asia Pacific Precision Medicine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis By Country
11.1.2. Y-o-Y Growth Projections By Country
11.1.3. Key Regulations
11.2. Market value Forecast By Technology, 2024–2031
11.2.1. NGS
11.2.2. Drug Discovery Technologies
11.2.3. Bioinformatics
11.3. Market value Forecast By Application, 2024–2031
11.3.1. Oncology
11.3.2. Immunology
11.3.3. Neurology
11.3.4. Cardiology
11.3.5. Infectious Diseases
11.3.6. Others
11.4. Market value Forecast By Country, 2024–2031
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia
11.4.5. New Zealand
11.4.6. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Technology
11.5.2. By Application
11.5.3. By Country
11.6. Prominent Trends
11.7. Drivers and Restraints: Impact Analysis
12. Middle East and Africa Precision Medicine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis By Country
12.1.2. Y-o-Y Growth Projections By Country
12.1.3. Key Regulations
12.2. Market value Forecast By Technology, 2024–2031
12.2.1. NGS
12.2.2. Drug Discovery Technologies
12.2.3. Bioinformatics
12.3. Market value Forecast By Application, 2024–2031
12.3.1. Oncology
12.3.2. Immunology
12.3.3. Neurology
12.3.4. Cardiology
12.3.5. Infectious Diseases
12.3.6. Others
12.4. Market value Forecast By Country, 2024–2031
12.4.1. GCC Countries
12.4.2. South Africa
12.4.3. Saudi Arabia
12.4.4. Rest of MEA
12.5. Market Attractiveness Analysis
12.5.1. By Technology
12.5.2. By Application
12.5.3. By Country
12.6. Prominent Trends
12.7. Drivers and Restraints: Impact Analysis
13. Competition Landscape
13.1. Competition Dashboard
13.2. Market Share Analysis By Company
13.3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
13.3.1. F. Hoffmann-La Roche AG
13.3.2. Illumina, Inc.
13.3.3. Thermo Fisher Scientific Inc.
13.3.4. QIAGEN
13.3.5. Quest Diagnostics
13.3.6. Laboratory Corporation of America Holdings
13.3.7. Novartis AG
13.3.8. AstraZeneca
13.3.9. Bristol-Myers Squibb
13.3.10. Eli Lilly And Company
14. Assumptions and Acronyms Used
15. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
